Cargando…

Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran

OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Farjadian, Shirin, Moghtaderi, Mozhgan, Kashef, Sara, Alyasin, Soheila, Najib, Khadijehsadat, Saki, Forough
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663315/
https://www.ncbi.nlm.nih.gov/pubmed/23724185
_version_ 1782270970529054720
author Farjadian, Shirin
Moghtaderi, Mozhgan
Kashef, Sara
Alyasin, Soheila
Najib, Khadijehsadat
Saki, Forough
author_facet Farjadian, Shirin
Moghtaderi, Mozhgan
Kashef, Sara
Alyasin, Soheila
Najib, Khadijehsadat
Saki, Forough
author_sort Farjadian, Shirin
collection PubMed
description OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentation of the disease in CF patients in southwestern Iran. METHODS: Twenty nine common CFTR gene mutations were examined in 45 CF patients. FINDINGS: Chronic cough, intestinal obstruction, dehydration, heat exhaustion and steatorrhea were the most common early clinical symptoms among our patients. The most common mutation was ΔF508, with an allele frequency of 21%. The homozygous ΔF508 mutation was observed in eight patients (18%), and three patients (7%) were ΔF508 carriers. The 2183AA > G mutation was observed in four patients, one of whom was also a ΔF508 carrier. The R1162X mutation was detected in two patients. The G542X, R334W and N1303K mutations were detected each in one patient, the first of whom was also a ΔF508 carrier. CONCLUSION: Out of 45 patients, 27 (60%) had none of the CFTR gene mutations we tested for. The most frequent mutations in southwestern Iranian patients with CF should be identified by sequencing the entire CFTR gene in order to optimize the design of a diagnostic kit for common regional mutations.
format Online
Article
Text
id pubmed-3663315
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Tehran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-36633152013-05-30 Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran Farjadian, Shirin Moghtaderi, Mozhgan Kashef, Sara Alyasin, Soheila Najib, Khadijehsadat Saki, Forough Iran J Pediatr Short Communication OBJECTIVE: Cystic fibrosis (CF) is a common autosomal recessive genetic disease caused by a mutation in the CF transmembrane conductance regulatory (CFTR) gene. This study attempted to identify the most common CFTR mutations and any correlations between certain mutations and the clinical presentation of the disease in CF patients in southwestern Iran. METHODS: Twenty nine common CFTR gene mutations were examined in 45 CF patients. FINDINGS: Chronic cough, intestinal obstruction, dehydration, heat exhaustion and steatorrhea were the most common early clinical symptoms among our patients. The most common mutation was ΔF508, with an allele frequency of 21%. The homozygous ΔF508 mutation was observed in eight patients (18%), and three patients (7%) were ΔF508 carriers. The 2183AA > G mutation was observed in four patients, one of whom was also a ΔF508 carrier. The R1162X mutation was detected in two patients. The G542X, R334W and N1303K mutations were detected each in one patient, the first of whom was also a ΔF508 carrier. CONCLUSION: Out of 45 patients, 27 (60%) had none of the CFTR gene mutations we tested for. The most frequent mutations in southwestern Iranian patients with CF should be identified by sequencing the entire CFTR gene in order to optimize the design of a diagnostic kit for common regional mutations. Tehran University of Medical Sciences 2013-04 /pmc/articles/PMC3663315/ /pubmed/23724185 Text en © 2013 Iranian Journal of Pediatrics & Tehran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Short Communication
Farjadian, Shirin
Moghtaderi, Mozhgan
Kashef, Sara
Alyasin, Soheila
Najib, Khadijehsadat
Saki, Forough
Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title_full Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title_fullStr Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title_full_unstemmed Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title_short Clinical and Genetic Features in Patients with Cystic Fibrosis in Southwestern Iran
title_sort clinical and genetic features in patients with cystic fibrosis in southwestern iran
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663315/
https://www.ncbi.nlm.nih.gov/pubmed/23724185
work_keys_str_mv AT farjadianshirin clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran
AT moghtaderimozhgan clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran
AT kashefsara clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran
AT alyasinsoheila clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran
AT najibkhadijehsadat clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran
AT sakiforough clinicalandgeneticfeaturesinpatientswithcysticfibrosisinsouthwesterniran